106 related articles for article (PubMed ID: 38201229)
1. Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype.
Jackson M; Serada N; Sheehan M; Srinivasan S; Mason N; Guha M; Avadhani N
PLoS One; 2018; 13(12):e0209489. PubMed ID: 30576337
[TBL] [Abstract][Full Text] [Related]
2. Proteomic Analyses Reveal the Role of Alpha-2-Macroglobulin in Canine Osteosarcoma Cell Migration.
Wilk SS; Michalak K; Owczarek EP; Winiarczyk S; Zabielska-Koczywąs KA
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612805
[TBL] [Abstract][Full Text] [Related]
3. Correction to "Establishment and characterization of a recurrent osteosarcoma cell line: OSA 1777".
J Orthop Res; 2024 Apr; 42(4):907. PubMed ID: 38014856
[No Abstract] [Full Text] [Related]
4. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms of Canine Osteosarcoma Metastasis.
Wilk SS; Zabielska-Koczywąs KA
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807419
[TBL] [Abstract][Full Text] [Related]
6. Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma.
Yang YT; Engleberg AI; Yuzbasiyan-Gurkan V
Cells; 2023 Dec; 13(1):. PubMed ID: 38201229
[TBL] [Abstract][Full Text] [Related]
7. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
8. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma.
Cam M; Gardner HL; Roberts RD; Fenger JM; Guttridge DC; London CA; Cam H
Oncotarget; 2016 Jul; 7(30):48533-48546. PubMed ID: 27391430
[TBL] [Abstract][Full Text] [Related]
9. MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines.
Lopez CM; Yu PY; Zhang X; Yilmaz AS; London CA; Fenger JM
PLoS One; 2018; 13(1):e0190086. PubMed ID: 29293555
[TBL] [Abstract][Full Text] [Related]
10. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
11. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
[TBL] [Abstract][Full Text] [Related]
12. First-in-Human Phase 1 Randomized Trial with the Anti-CD40 Monoclonal Antibody KPL-404: Safety, Tolerability, Receptor Occupancy, and Suppression of T-Cell-Dependent Antibody Response.
Samant M; Ziemniak J; Paolini JF
J Pharmacol Exp Ther; 2023 Dec; 387(3):306-314. PubMed ID: 37699709
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional profiling of canine osteosarcoma identifies prognostic gene expression signatures with translational value for humans.
Mannheimer JD; Tawa G; Gerhold D; Braisted J; Sayers CM; McEachron TA; Meltzer P; Mazcko C; Beck JA; LeBlanc AK
Commun Biol; 2023 Aug; 6(1):856. PubMed ID: 37591946
[TBL] [Abstract][Full Text] [Related]
14. ISG15 is a potential therapeutic target for osteosarcoma: a comprehensive analysis based on bioinformatics and in vitro experiments.
Liao Y; Zhang X; Tang J; Hu F; Li D; Song H; Chen J; Guo J; Li R; Lin Y; Xie L
Am J Transl Res; 2023; 15(2):817-833. PubMed ID: 36915723
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma.
Tan TJ; Ang WXG; Wang WW; Chong HS; Tan SH; Cheong R; Chia JW; Syn NL; Shuen WH; Ba R; Kaliaperumal N; Au B; Hopkins R; Li X; Tan AC; Seet AOL; Connolly JE; Arkachaisri T; Chew V; Lajam ABM; Guo D; Chew MZW; Wasser M; Kumar P; Albani S; Toh HC
Nat Commun; 2022 Oct; 13(1):6453. PubMed ID: 36307410
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]